The French Government Considers Buying Key Assets of Atos Amid Fears of Foreign Takeover

The French government has shown interest in buying certain key assets of Atos, the debt-laden technology company. The move is based on concerns that foreign investors, including hedge funds, could gain control of the firm after its upcoming restructuring plan. Paris has now sent a non-binding letter to purchase three strategic parts: super calculators for quantum computing used in the country’s nuclear weapons program; secure communication tech utilized by the military and cyber-security assets.

Data privacy and sovereignty have emerged as a significant topic across nations following large-scale cyberattacks exposing potential security risks. In this backdrop, acquiring stakes in companies dealing with sensitive information is critical to prevent such attacks or espionage by foreign entities.

National Assets vs Debt Burden

Atos had previously been seeki

Last week, out of the five working days that were traded in the country’s stock market, prices fell on four working days. In this, 85 percent of the companies have written their name in the price reduction list throughout the week. At the same time there was a big fall in the index. Orion Infusion has been a big surprise in price hikes in such a bearish market. In just five days, the company’s share price has collectively increased by more than Rs 232 crore. Which is 11.41 times more than the paid up capital of the company.

Over the past week, only 57 companies’ shares and units have entered the list of price increase in Dhaka Stock Exchange (DSE), the main stock market of the country. On the contrary, the price of 327 has decreased. Besides, the price of 10 remain

Yesterday, in Vontovorona, the École supérieure polytechnique d’Antananarivo (ESPA) officially received and put into service cutting-edge equipment in the fields of industrial electricity, home automation, telecommunications, IT and automobile manufacturing. This equipment is intended for practical and advanced work for students trained at Atelier Luban, a professional training center specializing in these sectors.

The president of ESPA underlined the importanc

On April 23, nine months have passed since the Alzheimer’s disease drug “Recanemab” (US name: Rekenbi) developed by Eisai and US Biogen was officially approved in the United States, but use widespread use of the drug has encountered unexpected obstacles. The photo shows Lynn Castellano receiving lecanemab treatment at the Medical Center in St. Louis, Missouri, in October 2023. Photo provided (2024 Reuters)

CHICAGO (Reuters) – Eisai ( 4523.T ) New Tab, opens a new tab and Biogen ( BIIB.O ) New Tab, opens a new tab developing Alzheimer’s disease drug “recanemab” (US name: Rekenbi) Nine months after to be officially approved in the United States, the widespread use of the drug faces unexpected obstacles. This is the strong belief that some doctors have that “treating dementia is meaningless.”

Alzheimer’s experts expected the various requirements associated with lecanemab treatment to be a barrier to uptake. These include additional diagnostic tests, intravenous fluids twice a month, and regular brain checks to prevent potentially fatal side effects.

Indeed, these issues contribute to the slow uptake of lecanemab, according to interviews with 20 neurologists and geriatricians in rural, urban, university and community clinics across 19 states.

But seven doctors who treat patients with Alzheimer’s disease said they were reluctant to prescribe lecanemab because of concerns about the drug’s effectiveness, cost and risks.

“I don’t think it’s a good Alzheimer’s drug, and that’s the problem,” said James Burke, a neurologist at Ohio State University and a vocal critic of lecanemab. “This is far from the home run we’re looking for,” he said.

The remaining si

Title: Tianjin Trading Group Achieves $468 Million in Intended Transactions at the 135th Canton Fair

Tianjin Northern Network News: On April 27, the second phase of the 135th Canton Fair concluded with impressive results for the Tianjin trading group. Preliminary statistics show that the group achieved a total of US$468 million in intended transactions during the first two phases of the fair.

Key exhibitors such as Tianjin Kainuo Industrial Co., Ltd., Tianjin Textile Group Import and Export Co., Ltd., and Tianjin Jiuding Sunshine Heating and Vent

Indeed, RAM allows sellers registered in its winning sales program called “VENGA” to accumulate points which are awarded in the form of gift cards.

On this occasion, the reg